Similar Stocks · Benchmarked Analysis · Peer Group

Peer Group Analysis

Configuration
Company Price d* Change d* Volume, Avg. k, d* Market Cap. d* Revenue Profit Net Earnings Free Cash Flow Dividend Yield P/E EPS Gross Margin % Net Margin % ROE % ROA % Quick Ratio % Shares Outstanding d*
Drug Manufacturers—General Average - - - - - - 130,127.50 8,409.05 475.64 19,256.35 796.05 0.01 1.9965 0.32 0.6174 -0.0307 0.00 0.03 0.8535 - -
Maximum - - - - - - 708,379.00 21,382.00 4,762.00 153,378.00 3,847.00 0.04 76.3636 2.71 0.8250 0.3012 0.05 0.53 3.5022 - -
Minimum - - - - - - 0.00 91.00 -11,911.00 -27,870.00 -2,626.00 0.00 -335.6404 -5.89 0.0683 -1.0039 -0.12 -0.72 0.0000 - -
Microsoft Corporation MSFT 25.16 0.03 0.12% 32 vs. 92 213,689.00 61,858.00 21,939.00 20,965.00 159,394.00 2.9500 35.9517 0.0018 0.7008 0.3547 0.0867 0.0453 1.0466 8,493.00
Pfizer Inc. PFE 24.80 -1.22 -4.69% 119,162 vs. 33,661 140,541.00 14,879.00 3,115.00 387.00 121,318.00 0.5500 12.5852 0.0151 0.7056 0.2094 0.0338 0.0141 0.5659 5,666.00
Moderna, Inc. MRNA 36.85 -2.92 -7.34% 24,324 vs. 5,845 14,180.00 167.00 -1,175.00 -1,185.00 12,431.00 -3.0800 -8.5828 0.0000 0.2096 -7.0359 -0.0917 -0.0702 3.7508 384.00
*d means the data is delayed 15 minutes at minimum.
More Due Diligence
Compare Fundamentals
Leverage our visualization and data tables to compare over 25 years of financial data for AAPL and its peers.
Watchlist
Keep an eye one one or all of the stocks by building a new watchlist.
Intrinsic Values
Utilize our versatile Gordan Growth Model for PFE.F and its peers to uncover potential buy and sell opportunities.